Senior Correspondent, London
Ben's Feed
Nov 6, 2014

AstraZeneca lifts sales forecast as Nexium keeps on giving

LONDON (Reuters) – AstraZeneca raised its 2014 sales forecast for the second quarter in a row on Thursday, as the delayed arrival of Nexium generics in the United States kept cash flowing from the heartburn and ulcer pill.

Britain’s second biggest drugmaker, which saw off a $118 billion takeover approach from Pfizer in May, now expects revenue to grow slightly this year, while earnings will fall less than previously expected.

Nov 5, 2014
Nov 5, 2014
Nov 3, 2014

Thermo Fisher pledges to fix glitch in drug analysis software

LONDON, Nov 3 (Reuters) – Thermo Fisher Scientific
has pledged to correct a glitch in software used to analyse data
from clinical drug trials within “four to eight weeks”, after
independent experts highlighted a potential for errors.

As Reuters reported exclusively last month, a problem with
the U.S. company’s Kinetica software package triggered concerns
about the reliability of tests used to win approval for some
drugs, particularly generic copies of original medicines.

Nov 3, 2014

Corrected: Ebola-carrying bats may be heroes as well as villains

LONDON (Reuters) – (Corrects name of journal to Science in paragraph 13)

Bats are living up to their frightening reputation in the world’s worst Ebola outbreak as prime suspects for spreading the deadly virus to humans, but scientists believe they may also shed valuable light on fighting infection.

Bats can carry more than 100 different viruses, including Ebola, rabies and severe acute respiratory syndrome (SARS), without becoming sick themselves.

Nov 3, 2014
Nov 2, 2014
Nov 2, 2014
Nov 2, 2014
Nov 2, 2014

Ebola-carrying bats may be heroes as well as villains

LONDON (Reuters) – Bats are living up to their frightening reputation in the world’s worst Ebola outbreak as prime suspects for spreading the deadly virus to humans, but scientists believe they may also shed valuable light on fighting infection.

Bats can carry more than 100 different viruses, including Ebola, rabies and severe acute respiratory syndrome (SARS), without becoming sick themselves.

    • About Ben

      "Ben Hirschler is European pharmaceuticals, biotechnology and healthcare correspondent, based in London. Previously, he was in charge of British company news and before that was posted to Johannesburg, covering the economic challenges facing post-apartheid South Africa."
    • More from Ben

    • Follow Ben